These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10381966)

  • 1. Immune response to rabies booster vaccination in subjects who had postexposure treatment more than 5 years previously.
    Naraporn N; Khawplod P; Limsuwan K; Thipkong P; Herzog C; Glueck R; Tantawichien T; Wilde H
    J Travel Med; 1999 Jun; 6(2):134-6. PubMed ID: 10381966
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 3. Early rabies antibody response to intramuscular booster in previously intradermally immunized travelers using human diploid cell rabies vaccine.
    Gherardin AW; Scrimgeour DJ; Lau SC; Phillips MA; Kass RB
    J Travel Med; 2001; 8(3):122-6. PubMed ID: 11468113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic response to rabies pre-exposure vaccination in persons with potential occupational exposure in Singapore.
    Lim PL; Barkham TM
    Int J Infect Dis; 2010 Jun; 14(6):e511-3. PubMed ID: 20018545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose.
    Zhang X; Zhu Z; Wang C
    Clin Vaccine Immunol; 2011 Sep; 18(9):1477-9. PubMed ID: 21752947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of purified vero cell rabies vaccine used in the treatment of fox-bite victims in India.
    Matha IS; Salunke SR
    Clin Infect Dis; 2005 Feb; 40(4):611-3. PubMed ID: 15712086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations.
    Kositprapa C; Limsuwun K; Wilde H; Jaijaroensup W; Saikasem A; Khawplod P; Kri-aksorn U; Supich C
    Clin Infect Dis; 1997 Sep; 25(3):614-6. PubMed ID: 9314448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postexposure rabies prophylaxis in immunosuppressed patients.
    Gibbons RV; Rupprecht CE
    JAMA; 2001 Mar; 285(12):1574-5. PubMed ID: 11268256
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody response to a single intradermal booster dose of rabies human diploid cell vaccine.
    Dreesen DW; Kemp DT; Brown J; Brown WJ
    J Am Vet Med Assoc; 1983 Dec; 183(12):1468-70. PubMed ID: 6654729
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity.
    Suwansrinon K; Wilde H; Benjavongkulchai M; Banjongkasaena U; Lertjarutorn S; Boonchang S; Suttisri R; Khowplod P; Daviratanasilpa S; Sitprija V
    Vaccine; 2006 May; 24(18):3878-80. PubMed ID: 16530893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of pre- and postexposure rabies vaccinations in a child infected with HIV.
    Pancharoen C; Thisyakorn U; Tantawichien T; Jaijaroensup W; Khawplod P; Wilde H
    Scand J Infect Dis; 2001; 33(5):390-1. PubMed ID: 11440231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One year booster vaccination with purified vero cell rabies vaccine.
    Suntharasamai P; Chanthavanich P; Supanaranond W; Warrell MJ
    Trans R Soc Trop Med Hyg; 1988; 82(4):633. PubMed ID: 3256120
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response in Dutch marines to a single intramuscular rabies booster immunization 1-2.5 years after an intradermal pre-exposure schedule: An observational study.
    De Pijper CA; Terryn S; Van Gucht S; Grobusch MP; Goorhuis A; Stijnis C
    Travel Med Infect Dis; 2020; 38():101907. PubMed ID: 33157228
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment.
    Vodopija I; Sureau P; Smerdel S; Lafon M; Baklaić Z; Ljubicić M; Svjetlicić M
    Vaccine; 1988 Jun; 6(3):283-6. PubMed ID: 3420976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postexposure rabies vaccination in patients infected with human immunodeficiency virus.
    Jaijaroensup W; Tantawichien T; Khawplod P; Tepsumethanon S; Wilde H
    Clin Infect Dis; 1999 Apr; 28(4):913-4. PubMed ID: 10825063
    [No Abstract]   [Full Text] [Related]  

  • 17. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults.
    Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE
    Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity study of abbreviated rabies preexposure vaccination schedules.
    Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P
    J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Antimalarial Drugs on the Immune Response to Intramuscular Rabies Vaccination Using a Postexposure Prophylaxis Regimen.
    Endy TP; Keiser PB; Cibula D; Abbott M; Ware L; Thomas SJ; Polhemus ME
    J Infect Dis; 2020 Mar; 221(6):927-933. PubMed ID: 31743394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV).
    Fayaz A; Simani S; Janani A; Farahtaj F; Biglari P; Howeizi N; Eslami N
    Vaccine; 2011 May; 29(21):3742-5. PubMed ID: 21458608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.